<?xml version="1.0" encoding="UTF-8"?>
<p>Overall, VL tended to decrease over time, and mean VL in the serum/plasma, saliva, and urine specimens was comparable, with 5.6 (± 1.2, range 2.9–8.1), 5.3 (± 0.8, range 3.2–6.9) and 4.5 (± 1.0, range 1.7–6.6) log
 <sub>10</sub> copies/ml, respectively, with serum attaining the highest VL peak at 8.1 log
 <sub>10</sub> copies/ml (
 <xref ref-type="fig" rid="pntd.0006518.g004">Fig 4</xref>). Interestingly, one contact had a serum VL of 6.7 log
 <sub>10</sub> copies/ml two days before symptom onset (data point excluded from 
 <xref ref-type="fig" rid="pntd.0006518.g004">Fig 4</xref>). Previous reports suggest prolonged maternal viremia in pregnant women [
 <xref rid="pntd.0006518.ref057" ref-type="bibr">57</xref>–
 <xref rid="pntd.0006518.ref060" ref-type="bibr">60</xref>]. While our sample size was very small, the four ZIKV rRT-PCR confirmed pregnant women in our study had a mean VL of 4.4 log
 <sub>10</sub> copies/ml ZIKV in urine (up to 7 days post-symptom onset) and mean VL of 3.5 log
 <sub>10</sub> copies/ml in serum/plasma (up to 5 days), comparable to non-pregnant subjects; however, the women were only followed for 21 days.
</p>
